Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evidium
San Francisco, California, United Statesevidium.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Evidium has developed a neuro-symbolic AI platform—Referenced AI—that combines generative and symbolic AI to deliver reliable, transparent, and explainable solutions for clinical workflows, analytics, and research in healthcare. The technology enables health systems, insurers, and pharmaceutical companies to manage knowledge at scale with traceability and compliance[1][2][3][4][6].
- Industry
- Digital Health Medical Devices
02
Partnerships
Syntropy (a partnership between EMD Digital/Merck KGaA and Palantir Technologies)Oracle Cloud Infrastructure (OCI) collaboration
Beyond the preview
Go deeper on Evidium.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Evidium.